Abazistobart, CAS 3002062-67-8

Product Description: Abazistobart is an immunostimulant and antineoplastic agent targeting the programmed cell death protein 1 (PDCD1). Abazistobart is a chimeric and humanized monoclonal antibody that specifically binds to PDCD1 to block the relevant signaling pathway, thereby activating the immune system and exerting antineoplastic activity. Abazistobart is promising for research of cancers[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.

CAS Number: 3002062-67-8

Molecular Weight: N/A

Research Area: Cancer; Inflammation/Immunology

Target: PD-1/PD-L1

• Artikelnummer: MEXHY-P991113-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P991113-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated